Intrinsic Value of S&P & Nasdaq Contact Us

PACS Group, Inc. PACS NYSE

NYSE • Financial Services • Financial - Conglomerates • US • USD

SharesGrow Score
69/100
3/7 Pass
SharesGrow Intrinsic Value
$151.20
+356.2%
Analyst Price Target
$44.67
+34.8%

PACS Group, Inc. (PACS) is a Financial - Conglomerates company in the Financial Services sector, currently trading at $33.14. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 3 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of PACS = $151.20 (+356.2% from the current price, the stock appears undervalued). Analyst consensus target is PACS = $45 (+34.8% upside).

Valuation: PACS trades at a trailing Price-to-Earnings (P/E) of 29 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.44.

Financials: revenue is $5.3B, +29.7%/yr average growth. Net income is $192M, growing at +56%/yr. Net profit margin is 3.6% (thin). Gross margin is 21.9% (+6.3 pp trend).

Balance sheet: total debt is $3.2B against $947M equity (Debt-to-Equity (D/E) ratio 3.38, leveraged). Current ratio is 1.07 (adequate). Debt-to-assets is 57.3%. Total assets: $5.6B.

Analyst outlook: 7 / 8 analysts rate PACS as buy (88%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 53/100 (Partial), Growth 100/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 53/100 (Partial), Future 94/100 (Pass), Income 30/100 (Fail).

$44.67
▲ 34.79% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for PACS Group, Inc., the average price target is $44.67, with a high forecast of $52.00, and a low forecast of $40.00.
Highest Price Target
$52.00
Average Price Target
$44.67
Lowest Price Target
$40.00

PACS SharesGrow Score Overview

69/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 53/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 53/100
Gross margin is + market cap
FUTURE 94/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PACS

~
VALUE Partial
53/100
PACS trades at a trailing Price-to-Earnings (P/E) of 29 (S&P 500 average ~25). Forward PEG 2.44 — overvalued. Trailing PEG 2.24. Analyst consensus target is $45, implying +35.8% from the current price $33. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
PACS: +29.7%/yr revenue is, +56%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
PACS: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet PACS: Debt-to-Equity (D/E) ratio 3.38 (leveraged), Current ratio is 1.07 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
53/100
PACS: Gross margin is 21.9% (+6.3 pp trend), $5B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 53/100. ≥ 70 = Pass.
View details →
FUTURE Pass
94/100
Analyst outlook: 7 / 8 analysts rate PACS as buy (88%). Analyst consensus target is $45 (+35.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
PACS: Net profit margin is 3.6%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range7.5-43.08
Volume748.61K
Avg Volume (30D)915.21K
Market Cap$5.21B
Beta (1Y)-0.65
Share Statistics
EPS (TTM)1.23
Shares Outstanding$156.18M
IPO Date2024-04-11
Employees32,433
CEOJason Murray
Financial Highlights & Ratios
Revenue (TTM)$5.29B
Gross Profit$1.16B
EBITDA$365.57M
Net Income$191.54M
Operating Income$309.6M
Total Cash$197.02M
Total Debt$3.2B
Net Debt$3B
Total Assets$5.58B
Price / Earnings (P/E)26.9
Price / Sales (P/S)0.98
Analyst Forecast
1Y Price Target$42.00
Target High$52.00
Target Low$40.00
Upside+26.7%
Rating ConsensusBuy
Analysts Covering8
Buy 88% Hold 13% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS69380Q1076

Price Chart

PACS
PACS Group, Inc.  ·  NYSE
Financial Services • Financial - Conglomerates
7.50 52WK RANGE 43.08
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message